1980
DOI: 10.1172/jci109828
|View full text |Cite
|
Sign up to set email alerts
|

Autologous Mixed Lymphocyte Reaction in Patients with Hodgkin's Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

7
41
1

Year Published

1982
1982
1990
1990

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 121 publications
(49 citation statements)
references
References 45 publications
7
41
1
Order By: Relevance
“…Increased spontaneous suppression of proliferative responses has been found in HD (Twomey et al, 1975;Goodwin et al, 1977;Twomey et al, 1980;Hillinger & Hertzig, 1978;Engleman, 1979) and may contribute to the defect in cell mediated immunity which is characteristic of patients with this disease. Con A-induced suppression of lymphocyte proliferation is either normal (Van Haelen & Fisher, 1981) or decreased (Schulof et al, 1980).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Increased spontaneous suppression of proliferative responses has been found in HD (Twomey et al, 1975;Goodwin et al, 1977;Twomey et al, 1980;Hillinger & Hertzig, 1978;Engleman, 1979) and may contribute to the defect in cell mediated immunity which is characteristic of patients with this disease. Con A-induced suppression of lymphocyte proliferation is either normal (Van Haelen & Fisher, 1981) or decreased (Schulof et al, 1980).…”
Section: Discussionmentioning
confidence: 99%
“…In HD there is an increase in suppressor activity for proliferation induced by mitogens (Goodwin et al, 1977;Twomey et al, 1980;Schulof et al, 1981) or cell bound alloantigens (Twomey et al, 1975;Hillinger & Hertzig, 1978;Engleman et al, 1979) which may contribute to the defect in cell-mediated immunity present in these patients (Twomey et al, 1975;Schulof et al, 1981). All these studies, however, have employed peripheral blood mononuclear cells (PB-MNC) and little information is available on the regulatory activity of tissue lymphocytes in this disease.…”
mentioning
confidence: 99%
“…The AMLR has been found to be deficient or absent in patients with various immunologic disorders such as systemic lupus erythematosus (14)(15)(16)(17), primary biliary cirrhosis (1 8), Sjogren's syndrome (1 91, several cancers (20), chronic lymphocytic leukemia (1,21), infectious mononucleosis (22), Hodgkin's disease (23), and Kaposi's sarcoma (24). The suppressive effect of aging on the AMLR has also been reported (25)(26)(27).…”
mentioning
confidence: 99%
“…To understand M+ functions during the immune response, these subpopulations need to be characterized and their functional relationships established. Subpopulation delineation is critical in studies involving tumor-bearing hosts (TBH), because tumor growth changes the immunoregulatory properties of M+ (6)(7)(8)(9)(10)(11)(15)(16)(17)(18)24,25,28,33,35,36) and changes also occur in M+ phenotype and function. Phenotypic changes in TBH M+ include changes in surface antigen (Mac-1, Mac-2, Mac-3, and Ia) expression (9)(10)(11)16,19,25,34), size distribution (341, and peroxidase staining (11).…”
mentioning
confidence: 99%
“…Phenotypic changes in TBH M+ include changes in surface antigen (Mac-1, Mac-2, Mac-3, and Ia) expression (9)(10)(11)16,19,25,34), size distribution (341, and peroxidase staining (11). Concomitant functional changes in TBH M+ include decreased accessory cell function in the allogeneic mixed lymphocyte reaction (MLR) (6,10,11,16,24), the autologous mixed lymphocyte reaction (AMLR) (8,35,36), and mitogen-induced T cell proliferation (7,9,10,25,33). These functional changes result from an altered suppressor M+ population (9,11,16,25,(34)(35)(36) and a decreased production of enhancing factors (18,28,35).…”
mentioning
confidence: 99%